JP2009521932A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521932A5
JP2009521932A5 JP2008548779A JP2008548779A JP2009521932A5 JP 2009521932 A5 JP2009521932 A5 JP 2009521932A5 JP 2008548779 A JP2008548779 A JP 2008548779A JP 2008548779 A JP2008548779 A JP 2008548779A JP 2009521932 A5 JP2009521932 A5 JP 2009521932A5
Authority
JP
Japan
Prior art keywords
polypeptide
variant
fragment
nucleic acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521932A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/049637 external-priority patent/WO2007076162A2/en
Publication of JP2009521932A publication Critical patent/JP2009521932A/ja
Publication of JP2009521932A5 publication Critical patent/JP2009521932A5/ja
Pending legal-status Critical Current

Links

JP2008548779A 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド Pending JP2009521932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
PCT/US2006/049637 WO2007076162A2 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Publications (2)

Publication Number Publication Date
JP2009521932A JP2009521932A (ja) 2009-06-11
JP2009521932A5 true JP2009521932A5 (https=) 2010-02-18

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548779A Pending JP2009521932A (ja) 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド

Country Status (8)

Country Link
US (1) US7985832B2 (https=)
EP (1) EP1966235A4 (https=)
JP (1) JP2009521932A (https=)
CN (1) CN101351474A (https=)
AU (1) AU2006330769A1 (https=)
BR (1) BRPI0621148A2 (https=)
CA (1) CA2632782A1 (https=)
WO (1) WO2007076162A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521932A (ja) 2005-12-29 2009-06-11 カンザス ステート ユニバーシティー リサーチ ファウンデーション 抗菌性カテリシジンペプチド
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
JP2010515685A (ja) 2007-01-08 2010-05-13 アンドロサイエンス コーポレーション （置換フェニル）−プロペナール部分を伴う化合物、その誘導体、生物学的活性およびその使用
CN101820765A (zh) * 2007-07-31 2010-09-01 安德鲁科技有限公司 包含雄激素受体降解(ard)增强剂的组合物和预防性或治疗性治疗皮肤病与脱发的方法
KR20100057640A (ko) * 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 인슐린 ｃ-펩티드 단독 또는 ｇｌｐ-1과의 배합물의 용도
WO2009043440A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
US20120149631A1 (en) * 2009-06-16 2012-06-14 George Mason Intellectual Properties, Inc Antimicrobial and antibiofilm activity of cathelicidins
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
AU2012332014B2 (en) 2011-10-31 2017-01-19 Kane Biotech Inc. Compositions and methods for preventing and treating oral diseases
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
MX2016010864A (es) 2014-02-21 2017-05-08 Avadim Tech Inc Metodo para el mantenimiento de cateteres uretrales.
JP2017519035A (ja) * 2014-06-27 2017-07-13 ケーン バイオテク インコーポレーテッド 抗微生物性−抗バイオフィルム性組成物及び該組成物のパーソナルケア製品のための使用
EP3244907B1 (en) 2015-01-13 2020-02-19 City of Hope Ctla4-binding protein peptide-linker masks
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
EP3541424A4 (en) * 2016-11-15 2020-10-28 The Rockefeller University CHEMERICAL ANTIBODIES INCLUDING BINDING DOMAINS OF PHAGE LYSINES, BACTERIAL AUTOLYSINS, BACTERIOCINS, AND PHAGE TAIL OR PHAGE TAIL FIBRILLES
WO2018094403A1 (en) * 2016-11-21 2018-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Novel antimicrobial and anti-cancer therapy
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
WO2005040192A2 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) * 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
JP2009521932A (ja) * 2005-12-29 2009-06-11 カンザス ステート ユニバーシティー リサーチ ファウンデーション 抗菌性カテリシジンペプチド
JP2010533705A (ja) * 2007-07-15 2010-10-28 ヒルマン，イチャク 抗菌ペプチドまたはその阻害剤を用いた疾病治療

Similar Documents

Publication Publication Date Title
JP2009521932A5 (https=)
Brogden et al. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Wu et al. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332
CN107735098B (zh) 抗微生物疗法
Rossi et al. Research advances in the development of peptide antibiotics
CN102482655A (zh) 抗微生物剂
Regmi et al. Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy
CN102702333B (zh) 抗耐药性病原菌感染多肽及其用途
JP2012526771A (ja) 抗真菌性ペプチドを含有する医薬組成物
US11649267B2 (en) Mitrecin A polypeptide with antimicrobial activity
CN106636050A (zh) 来源于耐甲氧西林金黄色葡萄球菌噬菌体的宽谱内溶素及其应用
RU2009134510A (ru) Рекомбинантный химерный белок фактора ингибирования нейтрофилов и гиругена и содержащая его фармацевтическая композиция
JP2012504958A5 (https=)
US7173007B1 (en) Therapy for microbial infections
JP2008520660A5 (https=)
JP2017533177A5 (https=)
JP2017533177A (ja) スイギュウ由来ペプチド抗生物質療法
CN115043924A (zh) 一种改造体抗菌肽及其应用
CN102018101A (zh) 一种南美白对虾抗菌肽制剂及其在水产养殖中的应用
KR102019153B1 (ko) 돌돔 유래의 항균 펩타이드 및 그의 용도
CN101817871B (zh) 迟缓爱德华氏菌密度感应系统阻断因子及其构建和应用
CN100345865C (zh) 一种抗菌二肽及其化学修饰物、制备方法与应用
CN104945494B (zh) 一种赤链华游蛇来源抗菌多肽sac及应用
CN118852364B (zh) 一种抗菌肽及其应用
JP2016521685A5 (https=)